NW
AZN icon

Naviter Wealth’s AstraZeneca AZN Stock Holding History

Naviter Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.16M Buy
31,249
+1,242
+4% +$239K 0.77% 25
2025
Q4 		$5.52M Sell
30,007
-6,007
-17% -$1.05M 0.72% 26
2025
Q3 		$5.53M Buy
36,014
+1,250
+4% +$189K 0.64% 29
2025
Q2 		$4.86M Buy
34,764
+1,268
+4% +$178K 0.6% 33
2025
Q1 		$4.94M Sell
33,496
-606
-2% -$87.7K 0.6% 35
2024
Q4 		$4.47M Sell
34,102
-688
-2% -$96.3K 0.54% 39
2024
Q3 		$5.42M Sell
34,790
-275
-0.8% -$44.4K 0.75% 30
2024
Q2 		$5.47M Buy
35,065
+3,484
+11% +$524K 0.82% 24
2024
Q1 		$4.28M Buy
31,581
+7,917
+33% +$1.05M 0.7% 30
2023
Q4 		$3.19M Buy
23,664
+2,177
+10% +$283K 0.64% 37
2023
Q3 		$2.91M Buy
21,487
+1,995
+10% +$272K 0.7% 29
2023
Q2 		$2.79M Buy
19,492
+2,476
+15% +$364K 0.71% 30
2023
Q1 		$2.36M Sell
17,016
-547
-3% -$73.6K 0.83% 23
2022
Q4 		$2.33M Buy
+17,563
New +$2.2M 0.64% 31
2022
Q3 		– Sell
-14,054
Closed -$1.86M – 183
2022
Q2 		$1.86M Buy
+14,054
New +$1.84M 0.76% 21

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Naviter Wealth's AZN Position: Q1 2026 in Review

Naviter Wealth increased its AstraZeneca (AZN) stake by 4.1% in Q1 2026, buying an estimated $239K and bringing the position to 31,249 shares worth $6.16M. The position accounts for 0.77% of the portfolio, ranked #25.

Naviter Wealth first reported a position in AZN in Q2 2022 and has held it in 15 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Naviter Wealth held 31,249 shares of AstraZeneca worth $6.16M as of Q1 2026.
  • Naviter Wealth bought 1,242 AstraZeneca shares in Q1 2026, an estimated $239K.
  • AstraZeneca made up 0.77% of Naviter Wealth's portfolio in Q1 2026, its #25 holding.
  • Naviter Wealth first reported a position in AstraZeneca in Q2 2022 and has held it in 15 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.